Gilbert, J., Othus, M., Raychaudhuri, S., Russell, K., Shaw, C., Vyas, R., Halpern, A., Hendrie, P., Mawad, R., Ghiuzeli, C. M., Cassaday, R., Walter, R., Ford, E., Appelbaum, J., Percival, M. (2025). Concurrent use of nucleoside reverse transcriptase inhibitors and purine analogs is associated with worse survival for patients with myeloid neoplasms: A single-center retrospective analysis. Blood. https://doi.org/10.1182/blood-2025-1677